BJUI Mini Reviews - Adjuvant Therapy of Renal Cell Carcinoma: Patient Selection and Therapeutic Options
Furthermore, significant achievements in the basic sciences have led to a greater knowledge of the underlying molecular genetics of RCC, which hold promise for increased sophistication in attempts to individualise patient prognostication and future treatment strategies.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
